IRIS
TERRANOVA, CORRADO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 5.922
NA - Nord America 967
EU - Europa 436
SA - Sud America 229
AF - Africa 21
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.583
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 4.990
US - Stati Uniti d'America 900
CN - Cina 452
HK - Hong Kong 312
BR - Brasile 172
IT - Italia 130
GB - Regno Unito 110
VN - Vietnam 85
DE - Germania 70
CA - Canada 41
AR - Argentina 23
NL - Olanda 20
CZ - Repubblica Ceca 18
IN - India 18
JP - Giappone 16
MX - Messico 16
FR - Francia 14
ZA - Sudafrica 10
CL - Cile 9
EE - Estonia 9
FI - Finlandia 9
TR - Turchia 9
ES - Italia 8
ID - Indonesia 8
SE - Svezia 7
AU - Australia 6
BD - Bangladesh 6
EC - Ecuador 6
PL - Polonia 6
RU - Federazione Russa 5
AT - Austria 4
CO - Colombia 4
DO - Repubblica Dominicana 4
IQ - Iraq 4
TW - Taiwan 4
UY - Uruguay 4
KR - Corea 3
NO - Norvegia 3
PE - Perù 3
PY - Paraguay 3
RS - Serbia 3
UA - Ucraina 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
BO - Bolivia 2
CH - Svizzera 2
EG - Egitto 2
HR - Croazia 2
JM - Giamaica 2
LB - Libano 2
LT - Lituania 2
MA - Marocco 2
MK - Macedonia 2
PT - Portogallo 2
SA - Arabia Saudita 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BY - Bielorussia 1
CU - Cuba 1
DZ - Algeria 1
GN - Guinea 1
GR - Grecia 1
HN - Honduras 1
HU - Ungheria 1
IE - Irlanda 1
KE - Kenya 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
ML - Mali 1
NG - Nigeria 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PK - Pakistan 1
RO - Romania 1
RW - Ruanda 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.583
Salva come PNG Salva come JPEG
Città #
Singapore 313
Hong Kong 304
Ashburn 224
Hefei 212
Boardman 116
London 86
Beijing 82
Shanghai 68
Rome 66
Santa Clara 66
Los Angeles 37
San Francisco 35
Munich 33
Ho Chi Minh City 32
Dallas 27
São Paulo 23
Washington 21
Buffalo 20
Montreal 19
Brno 18
Council Bluffs 18
Toronto 16
Amsterdam 14
Tokyo 14
Seattle 13
Secaucus 12
Hanoi 11
Brooklyn 10
Chicago 10
Pune 10
Grumo Nevano 9
Boston 8
Johannesburg 8
Milan 8
New York 8
Paris 8
Rio de Janeiro 7
Coral Springs 6
Haiphong 5
Mexico City 5
Naples 5
Phoenix 5
Santiago 5
Stockholm 5
Temecula 5
Warsaw 5
Biên Hòa 4
Buenos Aires 4
Canberra 4
Catania 4
Da Nang 4
Helsinki 4
Taipei 4
The Dalles 4
Thái Bình 4
Turku 4
Ankara 3
Anápolis 3
Charlotte 3
Cusano Milanino 3
Duque de Caxias 3
Guangzhou 3
Guayaquil 3
Hải Dương 3
Las Vegas 3
Lima 3
Louisville 3
Manaus 3
Medellín 3
Mysore 3
Newark 3
Nuremberg 3
Ribeirão Preto 3
Salvador 3
Seoul 3
Sonoma 3
Vĩnh Tường 3
Zhengzhou 3
Baghdad 2
Belo Horizonte 2
Belém 2
Brusaporto 2
Buford 2
Calgary 2
Cape Town 2
Chennai 2
Cleveland 2
Columbia 2
Cuautitlán Izcalli 2
Del Viso 2
Edinburgh 2
Elk Grove Village 2
Faella 2
Guarulhos 2
Hanover 2
Hyderabad 2
Isidro Casanova 2
Leeds 2
Linköping 2
Manchester 2
Totale 2.182
Salva come PNG Salva come JPEG
Nome #
Feasibility and efficacy of Letrozole in heavily pre-treated patients with relapsed ovarian cancer not eligible for further chemotherapy cycles 215
A comparison of three different entry techniques in gynecological laparoscopic surgery: a randomized prospective trial 211
Complications related to in vitro reproductive techniques support the implementation of natural procreative technologies 210
A randomized controlled trial comparing four versus six courses of adjuvant platinum-based chemotherapy in locally advanced cervical cancer patients previously treated with neo-adjuvant chemotherapy plus radical surgery 210
Assessment of quality of life and urinary and sexual function after radical hysterectomy in long-term cervical cancer survivors 204
The challenge of preoperative identification of uterine myomas: Is ultrasound trustworthy? A prospective cohort study 203
Efficacy of termoablative fractional CO2 laser (Monnalisa Touch) in stress urinary incontinence 202
Diet and Chemotherapy: The Effects of Fasting and Ketogenic Diet on Cancer Treatment 201
Feasibility of the use of novel matrix hemostatic sealant (FloSeal) to achieve hemostasis during laparoscopic excision of endometrioma 200
Does HE4 have a role as biomarker in the recurrence of ovarian cancer? 196
Analysis of ultrasonographic and hystopathologic features of placental invasiveness in Vitro Fertilization (IVF) pregnancies: a prospective study 194
Intravesical Instillations of Hyaluronic Acid as First-Line Treatment in Patients with Interstitial Cystitis/Bladder Pain Syndrome: Use, Efficacy and Effects on Quality of Life 193
Human embryo: what about relatedness? 193
Does HE4 have a role in the recurrence of ovarian cancer? 185
Intraoperative contact ultrasonography during open myomectomy for uterine fibroids 185
Anterior colporrhaphy plus inside-out tension-free vaginal tape for associated stress urinary incontinence and cystocele: 10-year follow up results 183
Chronic subtorsion of the ovary with subsequent ovarian hypoplasia 182
Role of BRCA Mutation and HE4 in Predicting Chemotherapy Response in Ovarian Cancer: A Retrospective Pilot Study 179
Chemotherapy as adjuvant treatment for intermediate-high risk early-stage endometrial cancer a pilot study 173
Can HE4 predict platinum response during first-line chemotherapy in ovarian cancer? 167
CARBOPLATINUM IN NEOADJUVANT CHEMOTHERAPY FOR LOCALLY ADVANCED CERVICAL CANCER: A PILOT STUDY. 167
Early Mini-Invasive Treatment of Persistent Cervical Dysplasia: Clinical Outcome and Psycho-Relational Impact 110
A critical review on HE4 performance in endometrial cancer: where are we now? 107
Role of Protopine and Nuciferine in the Management of Nocturia, Urgency, and Dysuria in Pre- and Postmenopausal Women: A Prospective Pilot Study 103
A Predictive Score for Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer (SeC-Score): A Single-Centre, Controlled Study for Preoperative Patient Selection 102
Effectiveness of human epididymis protein 4 (HE4) as predictor of response to first line platinum based chemotherapy 95
Does Extensive Upper Abdomen Surgery During Primary Cytoreduction Impact on Long-term Quality of Life? 94
C-reactive protein "at first sight": Standard postoperative trend in gynecological surgery and a comparative analysis with white blood cell levels 92
Afatinib, an irreversible ErbB family inhibitor, demonstrates activity against HER2 mutated cervical cancer in vitro 92
A randomized phase II study assessing an optimized schedule of oregovomab (0) anti-CA1 25 vaccination with carboplatin paclitaxel (CP) relative to CP alone in front-line treatment of optimally cytoreduced stage III/IV ovarian cancer (EOC) 91
A new type of absorbable barbed suture for use in laparoscopic myomectomy 91
Assessing HPV vaccination perceptions with online social media in Italy 90
Neoadjuvant chemotherapy plus radical surgery followed by chemotherapy in locally advanced cervical cancer 89
Implementing the Risk of Endometrial Malignancy Algorithm (REM) adding obesity as a predictive factor: Results of REM-B in a single-center survey 88
The use of sealing hemostat patch (HEMOPATCH®) in laparotomic myomectomy: a prospective case-control study 87
Economic impact among family caregivers of patients with advanced ovarian cancer 86
[The role of laparoscopy in ovarian carcinoma]. 86
Chirurgia Benigna 85
Feasibility and safety of carboplatin plus paclitaxel as neoadjuvant chemotherapy for locally advanced cervical cancer: a pilot study 80
Long-term follow-up of bulking agents for stress urinary incontinence in older patients 79
The Rendezvous Technique: A Minimally Invasive Non-Surgical Approach for the Management of Iatrogenic Ureteral Injuries 52
Front-line chemo-immunotherapy with carboplatin-paclitaxel using oregovomab indirect immunization in advanced ovarian cancer: A randomized phase II study 46
Ureteral injuries management in gynaecologic surgery: the role of the conservative approach 45
Miomectomia laparoscopica: fattibilità e learning curve 43
METODO PER LA DETERMINAZIONE DI UN INDICE PREDITTIVO DEL RISCHIO DI TUMORE DELL’ENDOMETRIO 41
Studio prospettico randomizzato comparativo tra due tecniche 40
PREOPERATIVE LOCAL STAGING OF ENDOMETRIAL CANCER: THE CHALLENGE OF IMAGING TECHNIQUES AND SERUM BIOMARKERS 38
Preoperative local staging of endometrial cancer: the challenge of imaging techniques and serum biomarkers 38
Laparoscopic myomectomy learning curve safety and feasibility. 38
The role of ovarian fossa evaluation in patients with ovarian endometriosis 37
Influence of pneumoperitoneum pressure on surgical field during robotic and laparoscopic surgery: a comparative study 37
The role of peritoneal lavage in benign gynecologic laparoscopic surgery 36
The Role of HE4, a Novel Biomarker, in Predicting Optimal Cytoreduction After Neoadjuvant Chemotherapy in Advanced Ovarian Cancer 36
Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition 35
PROGNOSTIC FACTORS AND BYOCHEMISTRY IN PATIENTS WITH OVARIAN CANCER: A NEW CLINICAL MODEL OF PREDICTION 35
Ovarian cancer relapse: From the latest scientific evidence to the best practice 34
REM (Risk of Endometrial Malignancy): a proposal for a new scoring system to evaluate risk of endometrial malignancy 33
Sentinel lymph node in cervical cancer: a literature review on the use of conservative surgery techniques 33
Quality of life in platinum-sensitive recurrent ovarian cancer: chemotherapy versus surgery plus chemotherapy 31
The True Impact of Voiding Dysfunctions after Transobturator Sub-Urethral Tape Procedures: A Systematic Review of Literature 30
Old Issues and New Perspectives on Endometrial Cancer Therapy: How Molecular Characteristics Are Changing the Therapeutic Pathway 29
Validation of REM score to predict endometrial cancer in patients with ultrasound endometrial abnormalities: results of a new independent dataset 29
The role of novel biomarker HE4 in the diagnosis, prognosis and follow-up of ovarian cancer: a systematic review 29
Tailoring parametrectomy for early cervical cancer (Stage IA-IIA FIGO): a review on surgical, oncologic outcome and sexual function 29
Use of music to reduce anxiety during office hysteroscopy: prospective randomized trial 29
Further insight into prognostic factors in endometrial cancer: the new serum biomarker HE4 28
Ovarian cancer recurrence and early detection: may HE4 play a key role in this open challenge? A systematic review of literature 28
Real-time infrared thermography for ureter detection during hysterectomy 28
Ten years of HPV vaccines: State of art and controversies 27
Prenatal genetic diagnosis: Fetal therapy as a possible solution to a positive test 26
Over-the-counter emergency contraception in Italy: ethical reflections and medico-legal issues 26
Neoadjuvant chemotherapy plus radical surgery followed by chemotherapy in locally advanced cervical cancer 26
The role of HE4 in endometrial cancer recurrence: how to choose the optimal follow-up program 26
Preeclampsia and the challenge of early prediction: reality or utopia? State of art and critical review of literature 25
European Menopause and Andropause Society (EMAS) and International Gynecologic Cancer Society (IGCS) position statement on managing the menopause after gynecological cancer: focus on menopausal symptoms and osteoporosis. 25
ECONOMIC IMPACT AMONG FAMILY CAREGIVERS OF ADVANCED OVARIAN CANCER PATIENTS 25
The Role of TAP/RS Block in Minor Gynecologic Laparoscopic Surgery: A Randomized Clinical Trial 24
Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix 24
Dual HER2/PIK3CA targeting overcomes single-agent acquired resistance in HER2-amplified uterine serous carcinoma cell lines in vitro and in vivo 24
The use of novel hemostatic sealant (Tisseel (R)) in laparoscopic myomectomy: a case-control study 24
Surgical treatment of rectovaginal endometriosis with extensive vaginal infiltration: results of a systematic three-step vagino-laparoscopic approach 24
Role of human epididymis protein 4 (HE4) in detecting recurrence in CA125 negative ovarian cancer patients 24
The role of macroplastique implantation in the management of occult urinary stress incontinence 24
The endogenous oxytocin after manipulative osteopathic treatment in full-term pregnant women 23
The impact of gynecologic oncology training in the management of cancer patients: is it really necessary? A prospective cohort study 23
Use of liposome encapsulated doxorubicin citrate (LEDC) as a valid drug in patients affected by ovarian cancer suffering from chemotherapy side-effects 23
The Role of Novel Serum Biomarker HE4 in Endometrial Cancer 22
TOTAL RECTOSIGMOIDECTOMY VERSUS PARTIAL RECTAL RESECTION IN ADVANCED OVARIAN CANCER SURGICAL DEBULKING: A CASE CONTROL STUDY 22
Suburethral sling in autoimmune patients: complications, quality of life, and success rate 22
RANDOMIZED CONTROL TRIAL COMPARING FOUR VERSUS SIX COURSES OF ADJUVANT PLATINUM-BASED CHEMOTHERAPY IN LOCALLY ADVANCED CERVICAL CANCER PREVIOUSLY TREATED WITH NEO-ADJUVANT CHEMOTHERAPY PLUS RADICAL SURGERY 22
Serous Tubal Intraepithelial Carcinoma (STIC): A Review of the Literature on the Incidence at the Time of Prophylactic Surgery 21
Hormone replacement therapy in cancer survivors: Utopia? 21
NOVEL BIOMARKER HE4 IN PREDICTING OPTIMAL CYTOREDUCTION AFTER NEO-ADJUVANT CHEMOTHERAPY (NACT) FOR ADVANCED OVARIAN CANCER 21
ROBOTIC PELVIC LYMPHADENECTOMY: STEPS AND TECHNIQUE 21
Role of human epididymis protein 4 (HE4) as predictor of response to platinum based chemotherapy: a systematic review of literature 20
Relaxant effect of proton pump inhibitors on in vitro myometrium from pregnant women 20
The role of human epididymis protein 4 as a biomarker in gynecologic malignancies 20
QUALITY OF LIFE IN PLATINUM-SENSITIVE RECURRENT OVARIAN CANCER: CHEMOTHERAPY VERSUS SURGERY PLUS CHEMOTHERAPY 20
Studio prospettico randomizzato comparativo tra due tecniche chirurgiche per il trattamento dell’incontinenza urinaria da sforzo: accesso retropubico vs transotturatorio 19
REM (RISK OF ENDOMETRIAL MALIGNANCY): A PROPOSAL FOR A NEW SCORING SYSTEM TO EVALUATE RISK OF ENDOMETRIAL MALIGNANCY 18
Totale 7.519
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.153
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.153
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022138 0 0 3 1 0 0 1 4 4 3 0 122
2022/202351 0 0 1 2 1 1 12 2 3 3 17 9
2023/2024491 10 42 46 43 43 147 4 64 9 20 30 33
2024/20255.876 107 25 122 33 27 98 83 65 276 341 2.288 2.411
2025/20261.077 313 168 182 399 15 0 0 0 0 0 0 0
Totale 7.633